EDAP TMS S.A (EDA) - Total Assets
Based on the latest financial reports, EDAP TMS S.A (EDA) holds total assets worth €74.55 Million EUR (≈ $87.15 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
EDAP TMS S.A - Total Assets Trend (2016–2025)
This chart illustrates how EDAP TMS S.A's total assets have evolved over time, based on quarterly financial data. Also see market cap of EDAP TMS S.A for the company's overall valuation and market capitalisation.
EDAP TMS S.A - Asset Composition Analysis
Current Asset Composition (December 2025)
EDAP TMS S.A's total assets of €74.55 Million consist of 72.4% current assets and 27.6% non-current assets. Review EDAP TMS S.A balance sheet liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 25.9% |
| Accounts Receivable | €21.29 Million | 27.0% |
| Inventory | €12.83 Million | 16.2% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €1.80 Million | 2.3% |
| Goodwill | €2.83 Million | 3.6% |
Asset Composition Trend (2016–2025)
This chart illustrates how EDAP TMS S.A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See EDAP TMS S.A (EDA) stock price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: EDAP TMS S.A's current assets represent 72.4% of total assets in 2025, a decrease from 86.9% in 2016.
- Cash Position: Cash and equivalents constituted 25.9% of total assets in 2025, down from 47.2% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, unchanged from 5.0% in 2016.
- Asset Diversification: The largest asset category is accounts receivable at 27.0% of total assets.
EDAP TMS S.A Competitors by Total Assets
Key competitors of EDAP TMS S.A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Limited
F:S5YA
|
Germany | €1.83 Billion |
|
China National Medicines Corp Ltd
SHG:600511
|
China | CN¥35.13 Billion |
|
China National Accord Medicines Corp Ltd
SHE:200028
|
China | HK$49.12 Billion |
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$8.80 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
EDAP TMS S.A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.60 | 1.51 | 4.34 |
| Quick Ratio | 1.38 | 1.05 | 3.77 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €22.17 Million | €20.36 Million | €49.76 Million |
EDAP TMS S.A - Advanced Valuation Insights
This section examines the relationship between EDAP TMS S.A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 17.45 |
| Latest Market Cap to Assets Ratio | 1.67 |
| Asset Growth Rate (YoY) | -8.2% |
| Total Assets | €79.00 Million |
| Market Capitalization | $132.10 Million USD |
Valuation Analysis
Above Book Valuation: The market values EDAP TMS S.A's assets above their book value (1.67x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: EDAP TMS S.A's assets decreased by 8.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for EDAP TMS S.A (2016–2025)
The table below shows the annual total assets of EDAP TMS S.A from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €79.00 Million ≈ $92.36 Million |
-8.21% |
| 2024-12-31 | €86.06 Million ≈ $100.62 Million |
-5.99% |
| 2023-12-31 | €91.55 Million ≈ $107.03 Million |
-9.47% |
| 2022-12-31 | €101.12 Million ≈ $118.22 Million |
+30.94% |
| 2021-12-31 | €77.23 Million ≈ $90.29 Million |
+39.92% |
| 2020-12-31 | €55.19 Million ≈ $64.53 Million |
+4.00% |
| 2019-12-31 | €53.07 Million ≈ $62.04 Million |
+8.88% |
| 2018-12-31 | €48.74 Million ≈ $56.98 Million |
+3.93% |
| 2017-12-31 | €46.90 Million ≈ $54.83 Million |
+0.66% |
| 2016-12-31 | €46.59 Million ≈ $54.47 Million |
-- |
About EDAP TMS S.A
EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications.… Read more